Peer Review History
| Original SubmissionSeptember 1, 2023 |
|---|
|
PONE-D-23-28265Prevalence and complete genome sequence of Lake Sinai virus from Apis mellifera in the Republic of KoreaPLOS ONE Dear Dr. Cho, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. While one reviewer was fully satisfied with your manuscript (which is highly unusual), the other reviewer was very critical and requests a number of improvements. I agree that your manuscript can be much stronger by considering these criticisms to improve the presentation of your interesting research. Please submit your revised manuscript by Dec 08 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Olav Rueppell Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file? [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: No Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Summary: The study reports a survey of Korean apiaries for strains of the LSV complex of viruses. The study does not appear to recognize the already existing set of assays or justify designing a new one, nor adequately determine the scope of that assay given the recognized high variation within the complex. The study does not sufficiently explain their sampling method and how it compares to other survey methods. Individual bees appear to have been used, even though pools of workers would generally be preferred to characterize colony-level health. Was sampling effort even among colonies and apiaries? Were colonies chosen in a randomized fashion from around the country? Some context as to the commercial/landscape status of the apiaries that were surveyed would be helpful, as these factors are important in colony health and disease transmission. The reporting of the work needs improvement in several aspects. First, the authors are inconsistent and inaccurate in describing their survey target, namely LSV2 based on a single accession and without regard for other primers already in the literature. The survey prevalence of LSV3 and LSV4 types do not appear to be based on targeted primer design but on accidental amplification of those types with the LSV2 primers. Second, the prevalence data would be better presented in a geographic context (ie a map of pie charts of detection rates) and the sequence similarity data is excessive with little apparent thought given to the utility of what is being presented and why. Specific comments: 1. Title must be modified to reflect the actual scope of LSV survey (eg LSV2), such as Prevalence and complete genome sequence of selected strains of Lake Sinai virus from Apis mellifera in the Republic of Korea. Also, how can the genomes be complete if they were generated by amplification and overlap? There is no way of knowing what sequence might be beyond the primers. 2. Line 55: The fact that nomenclature within LSV is ad hoc and does not necessarily reflect evolutionary relationships should be noted. To what extent lineages are evolutionary units comparable to species, and whether the polymerase or the whole genome should be used for phylogenetics, is not really resolved. ViralZone uses only LSV1 and LSV2, for example, whereas NCBI uses an inconsistent nomenclature (submitted by users) of numerous numbered and lettered strains. The strains were named essentially sequentially, rather than based on any comprehensive analysis of global sequence variation. LSV1 and LSV2 appear to be deep divisions within the overall variation, with other named types falling nearer one or the other of these two clades. 3. Line 53: Most authors identify four ORFs, see Bigot et al. While ORF4 has unusual properties and is not in all LSV relatives and may even be absent from some LSV, it should still be mentioned (see Shi et al., Bigot et al., Cornman, Karlin; see also https://www.uniprot.org/uniprotkb/?query=xref:embl-KX883223) 4. Lines 43-45: The first part of this sentence should be deleted as the association with colony health has already been noted. Instead, the point should just be that LSVs were first discovered in US surveys and subsequently demonstrated to be widespread in US. 5. Line 52: not accurate, many accessions are >6kb. 6. Line 63: There is no direct evidence that “LSV may cause behavioral changes in honeybees”, certainly not in the references cited for this statement. 7. Lines 66-73: this paragraph is redundant and unnecessary. 8. Line 82: “sample” does not appear to be defined. Individual worker bees? Of a particular age/caste/activity? 9. Line 97: what was the rationale for this primer design? Seems to be targeting LSV2 specifically. Why not based on an alignment of multiple LSV accessions to determine specificity? Most studies have had to use primers targeting a subset of LSV lineages due to the variability of the complex (but see Iwanowicz et al. 2020, https://doi.org/10.7717/peerj.9424). 10. Line 118: Ct < 35 is probably reasonable, but a bit arbitrary. Do the Ct values for negative and positive controls support this choice? 11. Line 127: this makes no sense as an a priori strategy. Presumably the initial amplicons were found to closely match the listed accessions rather than “LSV2”, and thus this strategy was undertaken? Please explain. 12. Line 136: searched against what database? NCBI nt database? 13. Line 139: “gaps were edited and calculated” means what? Manually aligned after initial clustal alignment? 14. Lines 259-268: At least two studies (Iwanowicz et al. 2020 and McMenamin et al. 2021) have detected LSV in other bee species as well, there may be additional reports I’m not aware of. 15. Line 149: LSV2 was targeted by primer design, but cross-amplification with other lineages was evident in the recovery of LSV3 and LSV4-like sequences. So language that reflects the limited and uncertain scope of the LSV assay needs to be used. For example, one could say “the LSV2 PCR assay was positive” rather than “LSV was present”. 16. Please show the results in their spatial context, ie a map with pie charts for each location rather than as bar plots. 17. Line 161: Earlier on line 138, the analyzed region was stated to be 460nt. 18. Line 176: what primers were used to determine LSV3 and LSV4 rates? Surely not the LSV2 primer set described in the methods, that produced the unexpected large amplicon? Primers should be designed for the purpose or else the results are potentially biased. 19. Line 82: it would be helpful to characterize the colonies in terms of use. Are these used for pollination services or honey? Are they transported during the year? Hobbyists, small commercial apiaries, large commercial apiaries? Agricultural environment? 20. I do not see the value of tables of percent identity among various accessions. Move to supplemental materials. 21. Line 252: all these cited studies used different sampling techniques, different assays, and different criteria for positives. There is no basis for directly comparing prevalence rates of the LSV complex by country, or at least the authors do not justify doing so. Nor are country borders particularly relevant to virus dispersal. Factors like economic trade zones, continents or biogeographic regions, ranges of mellifera subspecies, apicultural practice etc are probably more relevant. Reviewer #2: This is well written manuscript, interesting for publication. The Lake Sinai virus is emerging pathogen and valuable informations are presented in this manuscript with prevalence of diffrent genotypes, related to the severe or normal honeybee winter colonies losses. The manuscript is including also complete genomes of LSV2, LSV3 and LSV4 from Republic of Korea and comparison to the published sequences. I have no remarks. The manuscript is suitable for publication in the present form. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-23-28265R1Prevalence and Genome Features of Lake Sinai Virus Isolated from Apis mellifera in the Republic of KoreaPLOS ONE Dear Dr. Cho, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please carefully consider the thorough re-evaluation of the reviewer who was initially very critical. While progress has been noted, several serious issues remain to be resolved. Please submit your revised manuscript by Feb 19 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Olav Rueppell Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Summary: I appreciate the authors’ efforts to clarify their methodology and add context to their Introduction and Discussion. I still feel that the potential for primer bias is not fully acknowledged, despite the clear potential evident in Supplemental Figure S1, for example. The authors may have felt that the LSV2 accession used for primer design well represented previous results in the ROK, and they could also cite Hou et al. 2023 https://doi.org/10.1111/mec.16987, which shows continental genetic clustering within all the major LSV clades, as justification for their approach. Nonetheless, the paper makes many statements that gloss over ascertainment issues, such as in the abstract: “This study aimed to assess the prevalence of ... the LSVs ...from the ROK”). These claims overlook the fact that LSV1 is not assayed and assays for LSV2/LSV3/LSV4 have known primer mismatches with LSV2, LSV3, or LSV4 clade members. See also lines 81-86, line 109, and line 251 as examples where LSV is used instead of the specific LSV genotypes for which an assay was developed. Some additional comments are provided below. The authors continue to state that they have generated “complete genome sequences of LSV” using primers that do not start at position 1 of any reference and do not end at the final position of any reference. It is a minor point of no import for any conclusions, but these overlapped sequences cannot be called “complete” genomes, even if 99% of the bases are captured by the method. Line 221, for example, would need to be changed to “near-complete genome” or “partial genome”. Similarly, in the abstract the phrase “the first genome feature of the Korean “ should be changed to “the first near-complete genome sequences of Korean”. Nor is it certain whether the overlapped amplicons all come from a single virus strain, ie the assemblies could be chimeric. It has been previously documented that single individuals can harbor diverse strains (e.g. Ravoet et al; Iwanowicz et al.). Lines 53-54: Not correct as written, change to “with distinctive features that may be absent in some LSV clades”? Also, does “the evolutionary process” mean “replication” (line 54)? Line 65-66: “genotypes” rather than “gene types” The authors continue to state “LSV may cause behavioral changes in honeybees, leading to worker bees abandoning their hives” (lines 77-78). The cited references only show that LSV was found to be more prevalent in weak/collapsed hives than healthy. Nothing can be said about “behavioral changes in honeybees” caused by LSV. The fact that there may be a behavorial component to the colony collapse phenomenon does not mean LSV causes any behavior. Lines 142-143: I think “The alignment was generated and trimmed to the RdRp gene region in Bioedit” would be clearer. Lines 152-153: The BLASTN software is different from the database it was used to search. The default for BLASTN for the NCBI web service is the nt database, but any database can be used in principle. If nt was used, please explicitly state so for completeness/repeatability. Line 162: As the ANOVA is performed on proportions of positives within colonies, have the authors verified that the data are reasonably distributed? If not, a Kruskal-Wallis nonparametric test could be used instead. Line 166: “detection rate” instead of “infection rate” Line 168-170: if the overall detection rate of LSV2 was greater than 60%, how can the values on line 170 be considered high? Lines 176-178: the %id is lower for the LSV2 accession than the LSV3 and LSV4 accessions, in reverse order to what the text states. Line 182: this could just be due to primer bias – European like lineages might be present in ROK apiaries but not amplified. Line 274: What was the nature of the varroa samples? Were they collected from sticky boards, sugar roll, directly from parasitized adults or pupae? Were individual mites analyzed or pools? How were the twelve colonies selected for this assay? Also, what is your conclusion regarding the fact that your LSV4 assay was never positive in mites, although numerous positives in honeybees were obtained? Are patterns of discordance between the two species in S7 Table a matter of chance sampling or do you believe some species-level difference in LSV host interaction is occurring? Some discussion would be appreciated. Line 288-290: should note this is consistent with results of Hou et al. 2023, but also potentially an artifact of primer bias. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Prevalence and Genome Features of Lake Sinai Virus Isolated from Apis mellifera in the Republic of Korea PONE-D-23-28265R2 Dear Dr. Cho, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Olav Rueppell Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-23-28265R2 PLOS ONE Dear Dr. Cho, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Olav Rueppell Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .